Stock comparison
AbbVie Inc. is 23.2x more valuable than Viatris Inc by market capitalization ($441.54 B vs $19.03 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 23.2x more valuable than Viatris Inc by market capitalization ($441.54 B vs $19.03 B).
Market value leader
ABBV
AbbVie Inc. is 23.2x more valuable than Viatris Inc by market capitalization ($441.54 B vs $19.03 B).
Revenue leader
ABBV
VTRS: $14.30B vs ABBV: $61.16B.
Profit leader
ABBV
VTRS: $0.00 vs ABBV: $4.23B.
Margin leader
ABBV
VTRS: 0.0% vs ABBV: 6.9% net margin.
| Metric | VTRS | ABBV |
|---|---|---|
| Market cap | $19.03 B | $441.54 B |
| US-listed rank | #644 | #25 |
| Revenue (latest FY) | $14.30B | $61.16B |
| Net income (latest FY) | $0.00 | $4.23B |
| Net margin | 0.0% | 6.9% |
| P/E (trailing FY) | - | 104.5x |
| SEC filings | 519 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 23.2x more valuable than Viatris Inc by market capitalization ($441.54 B vs $19.03 B).
In their latest fiscal years, Viatris Inc reported $14.30B in revenue while AbbVie Inc. reported $61.16B.
Full pages: Viatris Inc and AbbVie Inc., or browse the full rankings.